FdCyd

N/A

Report date: 2024/01/02 20:03:52
NME

Base Information

Drug NameFdCyd
Drug Alias NameNSC-48006Ro-5-1090
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionDNA (cytosine-5)-methyltransferase 1 inhibitors
TargetsDNA (cytosine-5)-methyltransferase 1
Therapy Area/IndicationsMyelodysplastic SyndromesUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell Lung +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCity Of Hope National Medical CenterNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Institute
Inactive CompaniesCity Of Hope National Medical Center
Active IndicationsCarcinoma, Non-Small-Cell LungLung Neoplasms
Inactive IndicationsMyelodysplastic SyndromesUrinary Bladder NeoplasmsHead and Neck Neoplasms +[8] 

Other Information

ATC CodeN/A
Related LinksN/A